Form 8-K - Current report:
SEC Accession No. 0001104659-12-058616
Filing Date
2012-08-17
Accepted
2012-08-17 10:30:14
Documents
8
Period of Report
2012-08-16
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a12-18555_18k.htm 8-K 55341
2 EX-1.1 a12-18555_1ex1d1.htm EX-1.1 134793
3 EX-4.1 a12-18555_1ex4d1.htm EX-4.1 106813
4 EX-5.1 a12-18555_1ex5d1.htm EX-5.1 19773
5 EX-10.1 a12-18555_1ex10d1.htm EX-10.1 216068
6 EX-99.1 a12-18555_1ex99d1.htm EX-99.1 15707
7 GRAPHIC g185551ka01i001.jpg GRAPHIC 5721
8 GRAPHIC g185551mmi001.jpg GRAPHIC 5368
  Complete submission text file 0001104659-12-058616.txt   565336
Mailing Address 111 BARCLAY BLVD LINCOLNSHIRE IL 60069
Business Address 111 BARCLAY BLVD LINCOLNSHIRE IL 60069 8474780500
BIOSANTE PHARMACEUTICALS INC (Filer) CIK: 0001023024 (see all company filings)

IRS No.: 582301143 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-31812 | Film No.: 121041627
SIC: 2836 Biological Products, (No Diagnostic Substances)